Please try another search
Orient Pharma Co., Ltd. engages in the research and development, manufacturing, and sales of drugs in Taiwan and internationally. The company develops anti-psychotics and psychostimulants, as well as drugs for treating Parkinson’s and Alzheimer’s diseases; and products for the treatment of sialorrhea, tuberculosis, and attention deficit hyperactivity disorder. It is also developing drug delivery technologies, such as multi-stages-controlled release technology, trans-dermal patches, oral disintegrating tablets, sustained release technology, and micro granules. The company was founded in 2008 and is based in Taipei, Taiwan.
Name | Age | Since | Title |
---|---|---|---|
Ko-Hsin Hu | - | 2017 | Director |
Han-Liang Hu | 53 | - | Supervisor |
Amy Huang | - | 2017 | Independent Director |
Cheng Hong Ma | - | 2017 | Supervisor |
Thomas Chen | - | 2017 | Independent Director |
Peter Tsai | - | - | Chairman |
Hwa-Min Lin | - | - | Independent Director |
Wen-Foung Huang | - | - | Director |
Chih-Chen Cho | - | - | Supervisor |
Wei-Chao Kao | - | - | Director |
Calvin Tsai | - | - | GM & Director |
Phoebe Lee | - | - | Director |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review